cromolyn sodium has been researched along with Mast Cell Activation Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Christiansen, S; Doherty, TA; Kim, A; Zuraw, B | 1 |
| Butterfield, J; Castells, M | 1 |
| Afrin, LB; Dempsey, TT; Dorff, SR; Rosenthal, LS | 1 |
| Ehnes, A; Frieling, T; Homann, J; Kolck, UW; Molderings, GJ; Raithel, M | 1 |
| Abonia, JP; Ahrens, R; Blanchard, C; Brandt, EB; Cohen, E; Finkelman, FD; Forbes, EE; Foster, PS; Groschwitz, K; Hogan, SP; Matthaei, KI; McKenzie, A; Rothenberg, ME; Seidu, L; Strait, R | 1 |
| Krasagakis, K; Orfanos, CE; Stavropoulos, PG; Tebbe, B | 1 |
| Jensen, RT | 1 |
| Worobec, AS | 1 |
| Austen, KF; Horan, RF; Sheffer, AL | 1 |
| Greaves, MW; Mallet, AI; Norris, P; Rendell, NB; Wong, E | 1 |
4 review(s) available for cromolyn sodium and Mast Cell Activation Disease
| Article | Year |
|---|---|
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cromolyn Sodium; Disease Management; Glucocorticoids; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyurea; Interleukin-6; Leukotriene Antagonists; Leukotriene E4; Mastocytosis; Omalizumab; Prostaglandin D2; Tryptases | 2019 |
[Systemic mastocytosis--definition of an internal disease].
Topics: Algorithms; Apoptosis; Ascorbic Acid; Biopsy; Bone Marrow; Codon; Combined Modality Therapy; Cromolyn Sodium; Delayed-Action Preparations; Diagnosis, Differential; DNA Mutational Analysis; Drug Therapy, Combination; Gastrointestinal Diseases; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Ketotifen; Mast Cells; Mastocytosis; Phenotype; Proto-Oncogene Proteins c-kit | 2010 |
Gastrointestinal abnormalities and involvement in systemic mastocytosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cromolyn Sodium; Cross-Sectional Studies; Diagnosis, Differential; Digestive System; Eosinophilia; Esophageal Diseases; Gastric Acid; Gastrointestinal Diseases; Histamine Antagonists; Humans; Infant; Interferon alpha-2; Interferon-alpha; Intestinal Mucosa; Intestines; Liver Diseases; Malabsorption Syndromes; Mastocytosis; Middle Aged; Prospective Studies; Recombinant Proteins; Splenic Diseases; Urticaria Pigmentosa | 2000 |
Treatment of systemic mast cell disorders.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents; Aspirin; Cholinergic Antagonists; Clinical Trials as Topic; Combined Modality Therapy; Contraindications; Cromolyn Sodium; Diphosphonates; Flushing; Follow-Up Studies; Hematologic Diseases; Histamine Antagonists; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Leukemia, Mast-Cell; Mast-Cell Sarcoma; Mastocytosis; Osteoporosis; Photochemotherapy; Proto-Oncogene Proteins c-kit; Recombinant Proteins; Skin Neoplasms; Treatment Outcome | 2000 |
1 trial(s) available for cromolyn sodium and Mast Cell Activation Disease
| Article | Year |
|---|---|
Cromolyn sodium in the management of systemic mastocytosis.
Topics: Cromolyn Sodium; Double-Blind Method; Humans; Mastocytosis; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1990 |
5 other study(ies) available for cromolyn sodium and Mast Cell Activation Disease
| Article | Year |
|---|---|
Mast cell disorders: Protean manifestations and treatment responses.
Topics: Abdominal Pain; Adult; Anaphylaxis; Angioedema; Anti-Asthmatic Agents; Biomarkers; Cromolyn Sodium; Diarrhea; Dinoprost; Female; Histamine Antagonists; Humans; Leukotriene E4; Male; Mast Cells; Mastocytosis; Middle Aged; Omalizumab; Prostaglandin D2; Treatment Outcome; Tryptases; Urticaria | 2018 |
Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.
Topics: Administration, Topical; Adult; Anti-Allergic Agents; Anti-Asthmatic Agents; Cromolyn Sodium; Diphenhydramine; Dyspareunia; Female; Histamine Antagonists; Humans; Mast Cells; Mastocytosis; Metrorrhagia; Middle Aged; Pregnancy; Receptors, Histamine; Vaginitis | 2019 |
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.
Topics: Administration, Oral; Anaphylaxis; Animals; Antigens; Cromolyn Sodium; Disease Susceptibility; Fatty Acid-Binding Proteins; Gene Expression Profiling; Hypersensitivity; Interleukin-9; Intestines; Mast Cells; Mastocytosis; Mice; Mice, Transgenic; Ovalbumin; Permeability; Phenotype; Rats; Receptors, Interleukin-4; STAT6 Transcription Factor; Th2 Cells | 2008 |
Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations.
Topics: Adult; Aged; Anemia; Anti-Asthmatic Agents; Biomarkers; Bone Marrow Diseases; Cromolyn Sodium; Female; Gastrointestinal Diseases; Hepatomegaly; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Male; Mast Cells; Mastocytosis; Middle Aged; Prognosis; PUVA Therapy; Skin; Splenomegaly; Thrombocytopenia | 1998 |
The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.
Topics: Adult; Cromolyn Sodium; Female; Histamine; Humans; Imidazoles; Ketotifen; Male; Mastocytosis; Middle Aged | 1989 |